Christine Terre

Le Chesnay, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Rare case of PLAG1::RUNX1 fusion mimicking classical t(8;21): the value of optical genome mapping in acute myeloid leukemia.

Rare case of PLAG1::RUNX1 fusion mimicking classical t(8;21): the value of optical genome mapping in acute myeloid leukemia.

Journal: Molecular cytogenetics

Published: June 16, 2025

Deciphering Genomic Complexity of Multiple Myeloma Using Optimized Optical Genome Mapping.

Deciphering Genomic Complexity of Multiple Myeloma Using Optimized Optical Genome Mapping.

Journal: The Journal of molecular diagnostics : JMD

Published: August 29, 2024

Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients.

Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients.

Journal: Journal of hematology & oncology

Published: May 19, 2024

Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.

Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study.

Journal: Blood cancer journal

Published: April 03, 2024

The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique.

The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogénétique Hématologique.

Journal: American journal of hematology

Published: December 20, 2023

Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study.

Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study.

Journal: American journal of hematology

Published: November 28, 2023

Molecular characterization of adult IRF4 large B-cell lymphoma with spontaneous remission.

Molecular characterization of adult IRF4 large B-cell lymphoma with spontaneous remission.

Journal: Acta oncologica (Stockholm, Sweden)

Published: July 30, 2023

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study.

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study.

Journal: Blood advances

Published: March 08, 2023

AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome.

AML with inv(16)/t(16;16) and high-risk cytogenetic abnormalities: atypical features and unfavorable outcome.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 27, 2022

The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).

The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).

Journal: Leukemia

Published: November 24, 2021

Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study.

Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study.

Journal: Blood advances

Published: August 30, 2021

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.

Journal: Blood advances

Published: May 18, 2021

Showing 1-12 of 59

Last Updated: 09/26/2026